Literature DB >> 17522078

Cumulative attendance, assessment and cancer detection rate over four screening rounds in five English breast-screening programmes: a retrospective study.

Matthew Wallis1, Fergus Neilson, Helen Hogarth, Caroline Whitaker, Keith Faulkner.   

Abstract

BACKGROUND: Data collection in the National Health Service Breast Screening Programme monitors performance in a different cohort of women each year.
METHODS: This paper follows a single cohort study of 57,425 women (aged 50-53, when first invited) over four screening rounds to find: how many women attend screening and how often; how many were assessed; how many times they were assessed; and the number of cancers detected at each round.
RESULTS: Average attendance in each round was 76.9% and has remained constant. Only 62% of women have attended all four rounds, but 89.9% have been screened at least once, the average number of attendances being 3.5. Average assessment rate decreased from 7.3 to 3.5%. A total of 11.3% of women were assessed once, 0.91% twice and 0.06% three times. Cancer detection rates have more than doubled from 3.3 per 1000 screened to 6.9.
CONCLUSIONS: Current monitoring shows constant uptake over time, but when looking at a cohort of individual woman, a much larger percentage have 'ever' attended and a smaller number have attended all invitations. The chance of a woman being assessed at all, if she attends all four rounds, is 12.3%, which can be calculated by summating the recall rates in each round.

Entities:  

Mesh:

Year:  2007        PMID: 17522078     DOI: 10.1093/pubmed/fdm020

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  6 in total

1.  Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men.

Authors:  Julia E H Nolte; Till Neumann; Jennifer M Manne; Janet Lo; Anja Neumann; Sarah Mostardt; Suhny Abbara; Udo Hoffmann; Thomas J Brady; Juergen Wasem; Steven K Grinspoon; G Scott Gazelle; Alexander Goehler
Journal:  Eur J Prev Cardiol       Date:  2013-03-28       Impact factor: 7.804

2.  False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial).

Authors:  Louise E Johns; Sue M Moss
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-13       Impact factor: 4.254

3.  Benefits of the quality assured double and arbitration reading of mammograms in the early diagnosis of breast cancer in symptomatic women.

Authors:  Annika Waldmann; Smaragda Kapsimalakou; Alexander Katalinic; Isabell Grande-Nagel; Beate M Stoeckelhuber; Dorothea Fischer; Joerg Barkhausen; Florian M Vogt
Journal:  Eur Radiol       Date:  2011-11-18       Impact factor: 5.315

4.  Comparison of breast and bowel cancer screening uptake patterns in a common cohort of South Asian women in England.

Authors:  Charlotte L Price; Ala K Szczepura; Anil K Gumber; Julietta Patnick
Journal:  BMC Health Serv Res       Date:  2010-04-27       Impact factor: 2.655

5.  Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women.

Authors:  Shahpar Haghighat; Mohammad Esmaeil Akbari; Parvin Yavari; Mehdi Javanbakht; Shahram Ghaffari
Journal:  Iran J Cancer Prev       Date:  2016-02-23

6.  Cost- Effectiveness of Mammography Screening Program in a Resource-Limited Post-Soviet Country of Kazakhstan.

Authors:  Islam Salikhanov; Byron Crape; Peter Howie
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.